kõhrlagunemist

Kõhrlagunemist, also known as osteoporosis, is a systemic skeletal disease characterized by low bone mass and deterioration of bone tissue, leading to an increased risk of fractures. It is a silent disease, meaning that it often progresses without symptoms until a fracture occurs. The condition is more common in postmenopausal women, the elderly, and individuals with certain medical conditions such as rheumatoid arthritis or a history of long-term corticosteroid use.

The primary cause of kõhrlagunemist is an imbalance between bone resorption (breakdown) and bone formation (remodeling). This imbalance is influenced by various factors, including genetics, hormonal changes, lifestyle, and medical conditions. Vitamin D deficiency, calcium intake, and physical activity levels also play significant roles in the development and progression of the disease.

Diagnosis of kõhrlagunemist typically involves a bone mineral density test, such as a DEXA scan, which measures the amount of bone mineral in the body. Treatment options for kõhrlagunemist include lifestyle modifications, such as increasing calcium and vitamin D intake, engaging in weight-bearing exercises, and avoiding falls. Medications, such as bisphosphonates, hormone replacement therapy, and selective estrogen receptor modulators, may also be prescribed to slow bone loss and reduce the risk of fractures. Early detection and appropriate management are crucial for preventing complications and maintaining bone health.